text.skipToContent text.skipToNavigation
Need help? Please contact us
Pharma & Biotech

You searched for "CD34+ cells"

1,060 Products found
Too many choices? Use the filter option on the left to narrow your product listing.
  • 1(current)
  • 2
  • 3

You searched for "CD34+ cells"

1,039 Documents found
  • A Non-Viral Method for Modifying and Expanding Primary T Cells
    Learn how Lonza’s Cocoon® Platform, 4D-Nucleofector™ LV Unit and X-VIVO™ 15 Medium are integrated to enable non-viral genetic modification and subsequent expansion of primary T cells in a functionally-closed, automated workflow.
  • Instructions & Technical Info - Endothelial Cell Systems
    Technical Information and Instructions for Proper Use of Endothelial Cells
  • TechSheet - Normal Human Dendritic Cell System
    Technical Information Sheet for Poietics™ Normal Human Dendritic Cell System
  • TechSheet - Umbilical Vein Endothelial Cell Systems
    Technical information sheet for CloneticsTM HUVEC cells
  • TechSheet - Lung Blood Microvascular Endothelial Cell Systems
    Technical information sheet for Clonetics™ Lung Blood Microvascular Endothelial Cells
  • TechSheet - Dermal Blood Microvascular Endothelial Cell Systems
    Technical information sheet for Clonetics™ Dermal Blood Microvascular Endothelial Cells
  • Webinar - Clonetics™ Cells in Pancreatic Cancer Research
    Lonza_Webinars_Webinar_-_Clonetics_Cells_in_Pancreatic_Cancer_Research_pdf.pdf
  • TheraPEAK® X-VIVO® Hematopoietic Cell Culture Medium
    Serum-free, GMP produced medium for cell therapy applications
  • RAFT™ 3D Cell Culture System – Applications
    This presentation provides an overview of the various applications for which the RAFT™ 3D Cell Culture System has been used including the creation of cancer, corneal, airway, skin or blood brain barrier models.
  • TechSheet - Lung Lymphatic Microvascular Endo. Cell Systems
    Technical information sheet for Clonetics™ Lung Lymphatic Microvascular Endothelial Cells
  • TechSheet - Dermal Lymphatic Microvascular Endo. Cell Systems
    Technical information sheet for Clonetics™ Dermal Lymphatic Microvascular Endothelial Cells
  • Case Study – Improving the Expansion of Patients' T Cells
    In this serum-free media case study, learn how selection of memory T cells can aid in streamlining CAR-T therapies.
  • Transfection Protocol for Human T Cells (Stim.) - 96-well Shuttle™ Device
    Instructions of use for transfection of stimulated peripheral blood human T cells with the P3 Primary Cell 96-well Nucleofector™ Kit
  • The Cell and Gene Therapies Journey from Translation to Commercialization
    Download our comprehensive eBook on how to accelerate cell and gene therapy development, from translation to GMP production and commercialization.
  • Brochure
    Nucleofector™ Technology – Stretching Transfection Dimensions
  • Modeling Tumor-Stroma Interactions with the RAFT™ 3D Cell Culture System
    In this White Paper, we describe how to develop a spatially relevant collagen-based tumor model using the RAFT™ 3D Cell Culture System. This biomimetic 3D in vitro cancer model aims to mimic important aspects of the tumor microenvironment with respect to extracellular matrix (ECM) density, composition and spatial configuration.
  • Transfection Protocol for Mouse T cells (BALB/c) - Nucleofector™ I/II/2b Device
    Instructions of use for transfection of mouse T cells (BALB/c) with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • Transfection Protocol for mT cells (C57BL/6) - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of mouse T cells (C57BL/6) with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • First siRNA Library Screening in Hard-to-Transfect HUVEC and Jurkat Cells
    High throughput transfection of siRNA libraries has become a valuable tool in target identifi cation and validation. However, such screenings have so far been constrained to mostly easy-totransfect adherent cell lines. Lonza’s 96-well Shuttle® System, based on the well-established Amaxa® Nucleofector® Technology, extends these approaches to primary and diffi cult-to-transfect cells.
  • PBMC Based T Cell Proliferation Assay
    Protocol instructions
  • 3
  • 4(current)
  • 5